Thus, for bacterial sepsis where IL-1β facilitates septic shock, inhibition of GSDMD-mediated pore formation is considered an effective therapeutic strategy to prevent early shock caused by systemic hyperinflammation. The gene discussed is IL1B; the disease is bacterial infectious disease with sepsis.